Exclusive Summary

• Novel Mechanism & New Target
• This product is a non-steroidal drug with an entirely new mechanism of action targeting the aryl hydrocarbon receptor (AhR). It exerts comprehensive effects by inhibiting inflammation in atopic dermatitis, alleviating oxidative stress, promoting the restoration of skin barrier function, and providing antibacterial activity, thereby addressing the causes of atopic dermatitis from multiple perspectives.
• Superior Efficacy Breaking Through Traditional Limitations
• It features rapid onset of action: itching is relieved quickly after the first application, and significant improvements in lesion area and severity are observed at the first assessment. It is also the first topical agent to demonstrate excellent performance in achieving clinical clearance in patients.
• Overcoming the Limitations of Steroids
• Free of corticosteroids, this product has an excellent safety profile and is a first-line option for pediatric treatment, with approval for use in children as young as 2 years of age.

Asset Materials

Contact Us for Full Materials